Clinical Trials for Compass Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Compass Therapeutics

Clinical Trials (3)

NCT06548412
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
PHASE1/PHASE2Recruiting
50 participants
Started: Jan 22, 2025 · Completed: May 1, 2029
1 condition2 sponsors1 location
NCT06150664
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
PHASE1Recruiting
55 participants
Started: Mar 19, 2024 · Completed: Apr 30, 2026
5 conditions1 sponsor7 locations
NCT05506943
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
PHASE2/PHASE3Active, not recruiting
150 participants
Started: Jan 9, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor34 locations